EZH2 and ovarian carcinoma: In a cisplatin resistance of ovarian cancer cells study, the upregulation of miR-138-5p enhanced the chemosensitivity of DDP-resistant cells and apoptosis by decreasing the expression of EZH2 (Zhang et al., 2020).